Skip to main content
. 2019 May 28;19:645. doi: 10.1186/s12889-019-7004-x

Fig. 2.

Fig. 2

Description of HR-HPV genotype prevalence at baseline (a) and at follow-up (24 months after baseline) (b). Data corresponding to the anal site are on the left and data corresponding to the oral site are on the right: the prevalence is expressed as proportion respect to the number of subjects with HPV testing available (165 anal samples at baseline and at follow-up, 106 oral samples at baseline and 162 oral samples at follow-up). HR-HPV: high risk HPV genotypes. HPV: human papilloma virus